Two-Year Clinical Outcome of the TWENTE Trial, a Randomized Controlled Trial Comparing Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients

被引：0

作者：

von Birgelen, Clemens ^{[1
]}

Tandjung, Kenneth ^{[1
]}

Sen, Hanim ^{[1
]}

Basalus, Mounir ^{[1
]}

Louwerenburg, J. Hans ^{[1
]}

Stoel, Martin ^{[1
]}

van Houwelingen, K. Gert ^{[1
]}

Linssen, Gerard ^{[2
]}

Said, Salah ^{[3
]}

Nienhuis, Mark ^{[4
]}

Lowik, Marije ^{[1
]}

van der Palen, Job ^{[5
]}

Verhorst, Patrick ^{[1
]}

de Man, Frits ^{[1
]}

机构：

[1] Thoraxctr Twente, Enschede, Netherlands

[2] Ziekenhuisgrp Twente, Almelo, Netherlands

[3] Ziekenhuisgrp Twente, Hengelo, Netherlands

[4] Streekziekenhuis Koningin Beatrix, Winterswijk, Netherlands

[5] Univ Twente, NL-7500 AE Enschede, Netherlands

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2012年 / 60卷 / 17期

关键词：

D O I：

10.1016/j.jacc.2012.08.056

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：B15 / B15

页数：1

共 50 条

[31] 5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents Final Report of the DUTCH PEERS (TWENTE II) Trial
Zocca, Paolo
Kok, Marlies M.
Tandjung, Kenneth
Danse, Peter W.
Jessurun, Gillian A. J.
Hautvast, Raymond W. M.
van Houwelingen, K. Gert
Stoel, Martin G.
Schramm, Alexander R.
Gin, R. Melvyn Tjon Joe
de Man, Frits H. A. F.
Hartmann, Marc
Louwerenburg, J. W.
Linssen, Gerard C. M.
Lowik, Marije M.
Doggen, Carine J. M.
von Birgelen, Clemens
[J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (05) : 462 - 469
[32] Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial
Natsuaki, Masahiro
Kozuma, Ken
Morimoto, Takeshi
Kadota, Kazushige
Muramatsu, Toshiya
Nakagawa, Yoshihisa
Akasaka, Takashi
Igarashi, Keiichi
Tanabe, Kengo
Morino, Yoshihiro
Ishikawa, Tetsuya
Nishikawa, Hideo
Awata, Masaki
Abe, Mitsuru
Okada, Hisayuki
Takatsu, Yoshiki
Ogata, Nobuhiko
Kimura, Kazuo
Urasawa, Kazushi
Tarutani, Yasuhiro
Shiode, Nobuo
Kimura, Takeshi
[J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (10)
[33] Two-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Biodegradable or Durable Polymer
Natsuaki, Masahiro
Kozuma, Ken
Morimoto, Takeshi
Shiomi, Hiroki
Kimura, Takeshi
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (20): : 2125 - 2127
[34] Clinical Outcome of Diabetic and Non-Diabetic Patients Treated With Second-Generation Zotarolimus-Eluting and Everolimus-Eluting DES
Tandjung, Kenneth
Sen, Hanim
Basalus, Mounir
van Houwelingen, K. Gert
Lowik, Marije
Stoel, Martin
de Man, Frits
Louwerenburg, J. Hans
Linssen, Gerard
Nienhuis, Mark
Nijhuis, Rogier
van der Palen, Job
von Birgelen, Clemens
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B95 - B95
[35] TWO-YEAR CLINICAL OUTCOME OF THE NOBORI BIOLIMUS-ELUTING STENT VERSUS XIENCE/PROMUS EVEROLIMUS-ELUTING STENT IN REAL-WORLD CLINICAL PRACTICE
Kuramitsu, Shoichi
Hiromasa, Takashi
Kobayashi, Yohei
Jinnouchi, Hiroyuki
Morinaga, Takashi
Mazaki, Toru
Masuda, Hisaki
Domei, Takenori
Hyodo, Makoto
Shirai, Shinichi
Ando, Kenji
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1847 - A1847
[36] Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
Kedhi, Elvin
Joesoef, Kaiyum Sheik
McFadden, Eugene
Wassing, Jochem
van Mieghem, Carlos
Goedhart, Dick
Smits, Pieter Cornelis
[J]. LANCET, 2010, 375 (9710): : 201 - 209
[37] Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice
Lee, Joo Myung
Joh, Hyun Sung
Choi, Ki Hong
Hong, David
Park, Taek Kyu
Yang, Jeong Hoon
Song, Young Bin
Choi, Jin-Ho
Choi, Seung-Hyuk
Jeong, Jin-Ok
Lee, Jong-Young
Choi, Young Jin
Chae, Jei-Keon
Hur, Seung-Ho
Bae, Jang-Whan
Oh, Ju-Hyeon
Chun, Kook-Jin
Kim, Hyun-Joong
Cho, Byung Ryul
Shin, Doosup
Lee, Seung Hun
Hwang, Doyeon
Lee, Hyun-Jong
Jang, Ho-Jun
Kim, Hyun Kuk
Ha, Sang Jin
Shin, Eun-Seok
Doh, Joon-Hyung
Hahn, Joo-Yong
Gwon, Hyeon-Cheol
[J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (05)
[38] The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents A Substudy of the RESOLUTE All Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)
Stefanini, Giulio G.
Serruys, Patrick W.
Silber, Sigmund
Khattab, Ahmed A.
van Geuns, Robert J.
Richardt, Gert
Buszman, Pawel E.
Kelbaek, Henning
van Boven, Adrianus J.
Hofma, Sjoerd H.
Linke, Axel
Klauss, Volker
Wijns, William
Macaya, Carlos
Garot, Philippe
Di Mario, Carlo
Manoharan, Ganesh
Kornowski, Ran
Ischinger, Thomas
Bartorelli, Antonio L.
Gobbens, Pierre
Windecker, Stephan
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (22) : 2221 - 2232
[39] Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial
Harada, Yukinori
Colleran, Roisin
Kufner, Sebastian
Giacoppo, Daniele
Rheude, Tobias
Michel, Jonathan
Cassese, Salvatore
Ibrahim, Tareq
Laugwitz, Karl-Ludwig
Kastrati, Adnan
Byrne, Robert A.
[J]. CARDIOVASCULAR DIABETOLOGY, 2016, 15
[40] Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial
Yukinori Harada
Roisin Colleran
Sebastian Kufner
Daniele Giacoppo
Tobias Rheude
Jonathan Michel
Salvatore Cassese
Tareq Ibrahim
Karl-Ludwig Laugwitz
Adnan Kastrati
Robert A. Byrne
[J]. Cardiovascular Diabetology, 15

← 1 2 3 4 5 →